Gene · 7083
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-Omics Integration Analysis of TK1 in Glioma: A Potential Biomarker for Predictive, Preventive, and Personalized Medical Approaches. | Brain Sci | 2023 | 36831773 | PubTator, text mining | PubMed |
| Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types. | Cancers (Basel) | 2023 | 36831501 | PubTator, text mining | PubMed |
| Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev. | Cancers (Basel) | 2023 | 36831487 | PubTator, text mining | PubMed |
| CCNB2 as a potential biomarker of bladder cancer via the high throughput technology. | Medicine (Baltimore) | 2023 | 36820589 | PubTator, text mining | PubMed |
| The findings on the CEUS of diffuse large B cell lymphoma in abdomen: A case report and literature review. | Front Oncol | 2023 | 36816980 | PubTator, text mining | PubMed |
| Distinct stage-specific transcriptional states of B cells derived from human tonsillar tissue. | JCI Insight | 2023 | 36809296 | PubTator, text mining | PubMed |
| m5C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization. | Cell Death Dis | 2023 | 36806253 | PubTator, text mining | PubMed |
| Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers. | Comput Methods Programs Biomed | 2023 | 36804267 | PubTator, text mining | PubMed |
| Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? | Discov Oncol | 2023 | 36800051 | PubTator, text mining | PubMed |
| Identification of Drug Targets and Agents Associated with Hepatocellular Carcinoma through Integrated Bioinformatics Analysis. | Curr Cancer Drug Targets | 2023 | 36786134 | PubTator, text mining | PubMed |
| Depletion of plasma thymidine results in growth retardation and mitochondrial myopathy in mice overexpressing human thymidine phosphorylase. | J Biol Chem | 2023 | 36773803 | PubTator, text mining | PubMed |
| Spectral Dual-Layer Computed Tomography Can Predict the Invasiveness of Ground-Glass Nodules: A Diagnostic Model Combined with Thymidine Kinase-1. | J Clin Med | 2023 | 36769756 | PubTator, text mining | PubMed |
| HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas. | BMC Cancer | 2023 | 36750807 | PubTator, text mining | PubMed |
| Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma. | BMC Cancer | 2023 | 36721112 | PubTator, text mining | PubMed |
| Perceptual warping exposes categorical representations for speech in human brainstem responses. | Neuroimage | 2023 | 36720437 | PubTator, text mining | PubMed |
| Lipid biomarkers that reflect postoperative recurrence risk in lung cancer patients who smoke: a case-control study. | Lipids Health Dis | 2023 | 36707819 | PubTator, text mining | PubMed |
| The rocky road to organics needs drying. | Nat Commun | 2023 | 36681679 | PubTator, text mining | PubMed |
| The Impact of Molecular Biology in the Seeding, Treatment Choices and Follow-Up of Colorectal Cancer Liver Metastases-A Narrative Review. | Int J Mol Sci | 2023 | 36674640 | PubTator, text mining | PubMed |
| Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. | Int J Mol Sci | 2023 | 36674619 | PubTator, text mining | PubMed |
| Antitumor Effects of Poplar Propolis on DLBCL SU-DHL-2 Cells. | Foods | 2023 | 36673375 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7083/papers?page=17